Sponsored Content | Case Study | Radiation Therapy | September 30, 2019

Hypofractionation in the Age of Value-based Care

Today, Tomorrow and the Future. Are You Ready?

eBook on Hypofractionation in the Age of Value-based Care

eBook on Hypofractionation in the Age of Value-based Care

Radixact System with Synchrony

Radixact System with Synchrony

Hypofractionated and ultrahypofractionated radiation therapy — increasing dose per fraction to enable significantly fewer overall treatments — promises to unlock significant wins for public and private healthcare providers as well as the radiation oncology teams at the patient end of cancer treatment. While the drivers for hypofractionated procedures such as stereotactic body radiotherapy (SBRT) have been clear for some time — improved patient experience, increase d patient throughput and reduced cost of care — the challenge now is to identify new treatment tools and protocols to realize these clinical and economic outcomes at scale.

For starters, clinicians need the ability to maintain submillimeter accuracy and precision throughout treatment delivery — identifying the target location in the body; automatically detecting, tracking and correcting for target motion; and accurately repointing the beam in real-time to support the clinical use of smaller margins to reduce the side-effects of treatment. Between treatment fractions, radiation oncology teams also need tools to efficiently and seamlessly rework treatment plans to account for anatomical changes (see “Adaptive planning,” below). What’s more, none of this cutting-edge functionality can come at the expense of system versatility or patient throughput.

Put another way: the new standard in hypofractionated radiation therapy will be a treatment system that can deliver the highest level of accuracy and precision to both stationary and moving targets, along with the “workhorse versatility” to efficiently treat the full range of clinical indications.

To learn more, download the Accuray eBook on Hypofractionation in the Age of Value-based Care here: https://www.accuray.com/ebook/

Related Content

Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.

Getty Images

News | Lung Imaging | October 19, 2020
October 19, 2020 — Personalized treatment options for patients with...
Varian, a leading provider of cancer care technologies and solutions, continues to reinforce its commitment to delivering Intelligent Cancer Care during the 2020 American Society for Radiation Oncology (ASTRO) taking place virtually Oct. 24-31.
News | ASTRO | October 19, 2020
October 19, 2020 — ...
Mevion Medical Systems announced that it has shipped the accelerator module for the Mevion S250i Proton Therapy System to Kunshan, China. The 15-ton compact accelerator, the heart of the proton therapy system, is the smallest of its kind and will be the first in China.

Mevion's compact accelerator module is lifted and placed on a truck for the first leg of its journey to China. (Photo: Business Wire)

News | Proton Therapy | October 16, 2020
October 16, 2020 — Mevion Medical Systems announced that it has shipped the accelerator module for the...
Conducted by the University of Gothenburg, Lund University and the University of South Australia, the preclinical study found that dietary oat bran can offset chronic gastrointestinal damage caused by radiotherapy, contradicting long-held clinical recommendations.

Getty Images

News | Radiation Therapy | October 07, 2020
October 7, 2020 — Loved or hated, the humble oat could be the new superfood for cancer patients as international ...
Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma in situ (DCIS). Immuhistochemistry of estrogen receptor positive. Micrograph of breast cancer. Slide shows corresponding length of 1 mm.

Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma in situ (DCIS). Immuhistochemistry of estrogen receptor positive. Micrograph of breast cancer. Slide shows corresponding length of 1 mm. Getty Images

News | Breast Imaging | October 05, 2020
October 5, 2020 — A major study of women with ductal carcinoma in situ (...
ASTRO urges radiation oncology benefits management company eviCore to reconsider a move that requires shorter treatment regimens without regard for physician judgement

Getty Images

News | Radiation Oncology | October 02, 2020
October 2, 2020 — Radiation oncologists expressed serious concerns about a new private insurance coverage policy that
he Centers for Medicare and Medicaid Services (CMS) published the “Specialty Care Models to Improve Quality of Care and Reduce Expenditures (CMS-5527)” final rule.

Getty Images

News | Radiation Oncology | September 29, 2020
September 29, 2020 — On Sept.
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th